Happy as a pig
Wednesday, 20 August, 2008
Preliminary reports from the trial of Imugene’s [ASX: IMU] Porcine Reproductive and Respiratory Syndrome [PRRS] vaccine have contained some promising results.
Pigs which had been administered the vaccine showed much lower levels of lung lesions than the control group.
Furthermore, the results appear to show that both administration methods tested – oral and injection – had similar effects.
PRRS slows weight gain in infected pigs. While the injection method resulted in slightly lower lesion levels, pigs administered the vaccine orally showed higher levels of weight gain.
Proposed Australian trial eyes up blood testing for Alzheimer's
Utilising networks of GPs across three states, a large-scale study intends on combining digital...
Applications open for $300K pandemic therapeutics fellowships
Applications are now open for the Cumming Global Centre for Pandemic Therapeutics' inaugural...
CTA granted for CAR-T cell therapy for multiple myeloma
The Therapeutic Goods Administration has granted Clinical Trial Approval for KMCAR T-cell...
